Project Grant HT94252410664
Award Date
7/1/24
Completion Date
6/30/27
Dollars Obligated
$758K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Boston, MA 02114, USA
Similar Awards
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $557,438 project grant to the University of California, Los Angeles (UCLA) to investigate UCHL1 as a novel minimally invasive molecular indicator and therapeutic target for small cell lung cancer. This 2-year research project runs from September 15, 2023 to September 14, 2025 and will be conducted through UCLA's Office of Research Administration division. As a prime grantee, UCLA has also...
The Defense Health Agency has awarded a $893,000 Project Grant to the University of California, Los Angeles (UCLA) - Office of Research Administration to conduct research under the Military Medical Research and Development program (CFDA 12.420). This four-year grant, effective August 15, 2023 through August 14, 2027, will support UCLA's efforts to investigate the EGFR signaling network in glioblastoma, an aggressive form of brain cancer. As the prime grantee, UCLA will leverage its research...
The University of California, Los Angeles (UCLA), through its Office of Research Administration, has been awarded a $2,351,564.00 Project Grant from the Defense Health Agency under the CFDA Program 12.420 - Military Medical Research and Development. This four-year grant, with a period of performance from August 15, 2023 to August 14, 2027, will support research targeting the EGFR signaling network in glioblastoma. As the prime grantee, UCLA will leverage its research facilities, faculty...
This $188,403 federal Project Grant award was provided by the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program to the University of California, Los Angeles (UCLA) for the development of new cell-mediated immunotherapeutic strategies for small-cell lung cancer. The award has a performance period from January 1, 2025 to December 31, 2025. The funding supports advanced biomedical research initiatives focused on transforming...
This federal Project Grant award, valued at $2,520,000.00, was issued by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The award supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The primary awardee, the University of California, Los Angeles (UCLA), will leverage its extensive facilities, diverse faculty expertise, and robust administrative capabilities...
The Defense Health Agency awarded Massachusetts General Hospital a $582,732 project grant under the Military Medical Research and Development program to conduct research titled "Metabolic Targets to Overcome Chemoradiation Resistance in Genotype-Defined Non-Small Cell Lung Carcinoma." The CFDA number for the program is 12.420. Through this award spanning July 1, 2023 to June 30, 2025, MGH will investigate medical solutions for lung cancer treatment in military service members and the...
The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), was awarded a $577,094 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research aimed at "Redirecting Viral Immunity to Eradicate Low Tumor Mutation Burden Lung Cancers." The award period runs from Aug 31, 2023 to Aug 29, 2025. As a leading academic medical center and research institution, MGH utilizes its...
The University of California, Los Angeles (UCLA) has been awarded a $626,081 Project Grant under the Military Medical Research and Development (CFDA 12.420) federal grant program, administered by the Defense Health Agency. The grant, titled "Combinatorial Phenotype-Targeted Therapy to Overcome Mechanisms Driving Prostate Cancer Treatment Resistance," will support advanced biomedical research to transform healthcare for military service members and the broader public. The research...
The University of California, Los Angeles (UCLA) was awarded a $662,086 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from May 1, 2022 to April 30, 2025 to investigate NUDT5 as a novel target for ovarian cancer. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goal of transforming health care for...
This federal Project Grant award, valued at $1,498,368.00 and awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports advanced biomedical research initiatives at The General Hospital Corporation (Massachusetts General Hospital) to elucidate the molecular mechanisms of tumor-immune dynamics and evolution in response to radiation, with the goal of optimizing treatment of high- and very high-risk prostate cancer. The research...